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Seoul Neuropsychological Screening Battery-Dementia Version 
(SNSB-D): A Useful Tool for Assessing and Monitoring Cognitive 
Impairments in Dementia Patients
The Seoul Neuropsychological Screening Battery (SNSB) is one of the standardized 
neuropsychological test batteries widely used in Korea. However, it may be a bit too lengthy 
for patients with decreased attention span; and it does not provide the score of global 
cognitive function (GCF), which is useful for monitoring patients longitudinally. We sought 
to validate a dementia version of SNSB (SNSB-D) that was shorter than the original SNSB 
and contained only scorable tests with a GCF score of 300. We administered SNSB-D to 
patients with mild cognitive impairment (MCI) (n=43) and Alzheimer’s disease (AD) (n=93), 
and normal controls (NC) (n=77). MCI and AD groups had GCF scores significantly different 
from NC group, and GCF scores were able to distinguish patients with Clinical Dementia 
Rating of 0.5 and 1. Test-retest reliability was high, with a correlation coefficient of 0.918 
for AD, 0.999 for MCI, and 0.960 for NC. The GCF score significantly correlated with the 
Mini-Mental State Examination (MMSE). Through ROC-curve analysis, GCF scores were 
found to yield more accurate diagnoses than the MMSE. The SNSB-D is a valid, reliable tool 
for assessing the overall cognitive function, and can be used to monitor cognitive changes 
in patients with dementia.
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ORIGINAL ARTICLE
Neuroscience
INTRODUCTION
Neuropsychological tests are widely used to evaluate cognitive 
function in patients with brain injuries and neurological disor-
ders such as dementia. In patients with dementia, neuropsy-
chological testing is typically used to evaluate the presence and 
the severity of dementia, assign differential diagnoses, and mon-
itor the disease progression and the drug effects (1). 
  The Seoul Neuropsychological Screening Battery (SNSB) is a 
comprehensive neuropsychological test that assesses five cog-
nitive domains: attention, memory, language, visuospatial func-
tion, and frontal/executive function (2). The SNSB is one of the 
most commonly used neuropsychological tests in Korea for as-
sessing cognitive functioning in patients with stroke, head trau-
ma, Parkinson’s disease, and dementia. Although the SNSB is val-
id and reliable, with norms based on the analysis of 447 healthy 
subjects (2), several limitations of this battery have been identi-
fied. First, it has been suggested that the length of time taken to 
administer the test may be excessive for some patients with de-
mentia, especially those with compromised attention spans. Sec-
ond, although it is possible to evaluate each cognitive domain 
individually, the battery does not provide a global cognitive func-
tion (GCF) score, which may be useful for longitudinal monitor-
ing of the disease progression. Third, it may be difficult to quan-
tify the decline of frontal/executive function in patients of inter-
est across time using SNSB, because the subtests assessing fron-
tal/executive function include some tests that are qualitative in 
nature. 
  The main purpose of this study is to develop a dementia ver-
sion of SNSB (SNSB-D) that was modified from the original SNSB 
such that it can be more easily applicable to patients with de-
mentia for both clinical and research purposes. The SNSB-D dif-
fers from the original SNSB in the following ways: it provides a 
GCF score that represents a sum of the five cognitive domains 
assessed; it was shortened to reduce overall testing time; and it 
includes a method for converting qualitative items into a quan-
titative score. In order to evaluate the validity and reliability of 
the SNSB-D for assessing patients with memory impairment 
and dementia, we tested the SNSB-D in patients with mild cog-
nitive impairment (MCI), Alzheimer’s disease (AD), and a nor-
mal control group (NC).
MATERIALS AND METHODS
Participants
Participants in this study included 93 patients with AD and 43 
patients with amnestic MCI (aMCI) who were recruited from 
the Memory Disorder Clinic at the Samsung Medical Center in Ahn HJ, et al.  •  Seoul Neuropsychological Screening Battery-Dementia Version (SNSB-D)
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Seoul, Korea from November 2005 to January 2007. All patients 
with AD met the criteria for probable AD proposed by the Na-
tional Institute of Neurological and Communicative Diseases 
and Stroke and Alzheimer’s disease and Related Disorders As-
sociation (NINCDS-ADRDA) (3). The aMCI patients were diag-
nosed according to the criteria proposed by Peterson et al. (4): 1) 
subjective memory complaint as described by the patient and/
or caregiver, 2) normal general cognitive function, as defined by 
a score of 24 or greater on the Korean version of Mini-Mental 
State Examination (MMSE), 3) ability to participate in normal 
activities of daily living (ADL), judged clinically and by an ADL 
scale, 4) objective memory decline below the 16th percentile on 
neuropsychological tests, and 5) non-conformance to clinical 
criteria for diagnosis of dementia.
  All patients underwent a comprehensive evaluation consist-
ing of a detailed medical history, neurological examinations, and 
a neuropsychological evaluation (SNSB). Additionally, labora-
tory tests were used to confirm that there were no secondary 
causes for dementia or cognitive impairment. Magnetic Reso-
nance Imaging (MRI) was performed on all patients, and all pa-
tients with structural brain lesions or severe white matter isch-
emia (caps or band >10 mm and deep white lesion >25 mm) were 
excluded. Patients who were illiterate were also excluded, regard-
less of formal education status.
  The normal control (NC) group consisted of 77 healthy spous-
es or caregivers of patients from the memory disorder clinic. All 
controls were screened for neurological and psychiatric illness-
es, and those who were identified to have any of these illnesses 
were excluded from the study. All subjects in the NC group met 
the criteria for healthy controls proposed by Christensen et al. 
(5) and did not have dementia as defined by the score below 8 
points on the Korean Dementia Screening Questionnaire (KDSQ) 
(6) as well as by an ADL score less than 8 on Seoul Instrumental 
Activities of Daily Living (S-IADL) (7).
  The three groups included in this study did not differ signifi-
cantly in age, education level, and gender. In terms of Clinical 
Dementia Rating (CDR) scores (8), all participants in the NC 
group had a CDR score of 0; all patients in the MCI group had   
a CDR score of 0.5; and of the participants in the AD group 35 
had a CDR score of 0.5 (mild stage, 38%), 42 had a CDR score of 
1 (mild to moderate stage, 45%), and 16 had a CDR score of 2 
(moderate stage, 17%). Among patients with AD, the CDR groups 
did not differ in age, education level, and gender. We obtained 
informed consents from all the patients and controls, and this 
study was approved by the Institutional Review Board of Sam-
sung Medical Center (2005-02-008).
Construction of SNSB-D
Like the original SNSB, the SNSB-D consists of sub-domains as-
sessing attention, language and related function, visuospatial 
function, memory, and frontal/executive function (Table 1). We 
devised a GCF score drawn from the results of the SNSB-D that 
includes a maximum of 300 points, which is the sum of each sub-
domain with 17/300 (6%) from attention, 27/300 (9%) from lan-
guage and related function, 36/300 (12%) from visuospatial func-
tion, 150/300 (50%) from memory, and 70/300 (23%) from fron-
tal/executive function.
  Table 1 summarizes the differences between the SNSB-D and 
Table 1. Construction and scoring system for the SNSB-D and modifications from the original SNSB
Domains Score    % Subtests Maximum points Modification from original SNSB
Attention   17     6 Digit span forward
Digit span backward
  9
  8
None
Language and
  related function
  27     9 Short form of K-BNT (A form)
Calculation
(3 items each for addition,  
subtraction, multiplication, division)
15
12
Short form instead of the full 60 item version of K-BNT
Excluded items: spontaneous speech, auditory 
comprehension, repetition, reading, writing, four 
components of Gerstmann syndrome, limb and 
buccofacial praxis
Visuospatial function   36   12 RCFT copy 36 None
Memory 150   50 Orientation
SVLT free/delayed recalls
SVLT recognition
RCFT immediate/delayed recalls
RCFT recognition
  6
48
12
72
12
Out of 10 orientation items, season,
country, city, and floor were excluded
Frontal/Executive function   70   23 Motor impersistence
Contrasting program
Go-no-go test
Fist-edge-palm
Luria loop
Category word generation (animal)
Phonemic word generation (ㄱ)
Stroop test-color reading
  3
  3
  3
  3
  3
20
15
20
Excluded items: alternating hand movement, 
alternating square and triangle, category word 
generation (supermarket), phonemic word generation 
(ㅇ, ㅅ), Stroop test-word reading
GCF score 300 100
K-BNT, Korean-Boston naming test; RCFT, Rey-complex figure test; SVLT, Seoul verbal learning test; GCF, global cognitive function.Ahn HJ, et al.  •  Seoul Neuropsychological Screening Battery-Dementia Version (SNSB-D)
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the original SNSB, and describes how the SNSB-D was modified 
from the original SNSB. The attention domain score was derived 
from the sum of the raw scores for forward and backward digit 
span. Of the many items that assess language and related func-
tions, only naming and calculation tests were included. Specifi-
cally, a shortened version (15 item version, Form A) of the Ko-
rean version of the Boston Naming Test (K-BNT) and 12 trials of 
written calculations (three trials each for addition, subtraction, 
multiplication, and division) were included. The copying test 
from the Rey Complex Figure Test (RCFT) was used to assess 
visuospatial function. Several domains of memory function were 
assessed, including orientation, verbal memory, and visual mem-
ory. Orientation was assessed using four measures assessing 
orientation to time (year, month, date, day of the week) and two 
items assessing orientation to place (“What is this place for?” and 
“What’s the name of this place?”). The verbal memory score was 
derived from the sum score of three recall trials, a delayed recall 
task, and a recognition task from the Seoul Verbal Learning Test 
(SVLT). The visual memory score was composed of the sum of 
the scores from the immediate recall, delayed recall, and recog-
nition scores of the RCFT. The frontal/executive function sub-
domain was assessed using motor impersistence, contrasting 
program, go-no-go test, fist-edge-palm task, and the Luria loop 
task, each of which were rated on a 0 to 3 scale. Additionally, a 
word fluency and Stroop color-reading test were administered. 
For the word fluency test, a category word generation task (ani-
mal) and a phonemic word generation task (‘ㄱ’/g/) were given, 
with a maximum score of 20 for the category word generation 
task and 15 for the phonemic word generation task. Thus, if the 
number of appropriate words generated was greater than 20 or 
15, respectively, the measure was scored as 20 and 15 points. 
Stroop test score was converted to a maximum score of 20 by 
dividing the number of correct responses of color reading test 
by 5 and dropping the digits after the decimal points. Because of 
the shortening of several tests from the original SNSB as describ–
ed in the above, it takes about 40-50 min to administer the SNSB-
D compared with 60-80 min to complete the original SNSB. 
Test-retest reliability
To assess test-retest reliability, the SNSB-D was readministered 
one to three months (mean=51 days) following the initial test in 
10 patients with AD, three patients with MCI, and eight partici-
pants from the NC group. 
Statistical analysis
Data were analyzed using SPSS 13.0. ANOVA was used to com-
pare age and education levels across groups, and a chi-square 
test was used to compare gender across groups. To verify the dis-
criminant validity of the SNSB-D, GCF scores were compared 
among all groups. To examine discriminant validity based on 
severity of dementia, all subjects were classified into four groups 
(CDR 0, 0.5, 1, 2), and GCF scores were compared among these 
four groups. To examine the convergent validity of the SNSB-D, 
Pearson correlation coefficients were calculated for the SNSB-D 
and the MMSE. The reliability of the SNSB-D was evaluated by 
assessing internal consistency and test-retest reliability. Cron-
bach’s alpha was used to test for internal consistency, and Pear-
son correlation coefficients were used to test for test-retest reli-
ability among each of the groups.
  To evaluate the diagnostic utility of the SNSB-D, we examined 
the sensitivity and specificity of SNSB-D, using a receiver oper-
ating characteristics (ROC) curve. Discrimination ability of GCF 
score derived from the SNSB-D was compared with the results 
of MMSE using area under the curve (AUC) analyses. 
RESULTS
Discriminant validity by group analysis
GCF scores differed significantly among the groups (NC, MCI 
and AD; P<0.001; Table 2). Tukey’s post hoc analyses were used 
Table 2. Mean scores of the MMSE and the SNSB-D in the NC, MCI and AD groups
Group (CDR)
NC MCI AD
P value
(0) (0.5) (0.5) (1) (2)
MMSE 28.6±1.4 27.2±1.9 (20.2±3.7) 19.2±5.0 (19.0±4.0) (13.4±4.6) <0.001
Attention 10.0±2.1 9.4±2.1 (8.3±2.1) 7.6±2.1 (7.4±2.0)   (6.3±2.0) <0.001
Language and
   related function
24.1±2.8 21.1±3.7 (18.1±5.2) 15.5±5.7 (15.6±4.5)   (9.7±5.5) <0.001
Visuospatial
   function
33.8±2.5 32.2±4.0 (26.8±11.1) 21.5±12.3 (22.0±10.5)   (8.4±9.7) <0.001
Memory
   Verbal memory
   Visual memory
88.3±15.3
39.6±7.2
42.7±12.4
56.0±16.3
27.6±8.2
22.8±12.9
(31.8±11.3)
(16.6±5.2)
(10.9±7.5)
24.6±11.9 (23.0±10.2)
13.2±6.2 (12.7±5.6)
8.2±6.9 (7.6±6.6)
(13.0±5.0)
  (7.3±4.7)
  (3.8±3.4)
<0.001
<0.001
<0.001
Frontal/Executive
   function
54.8±9.2 48.2±10.9 (35.8±10.6) 28.1±12.2 (25.6±10.1)   (17.9±10.7) <0.001
GCF score 211.0±24.3 166.9±28.9 (120.7±28.3) 97.2±35.5 (93.6±27.1)   (55.2±26.6) <0.001
NC, normal control; MCI, mild cognitive impairment; AD, Alzheimer’s disease; MMSE, Mini-Mental State Examination; SNSB-D, dementia version of Seoul Neuropsychological 
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to examine differences in GCF scores between each of the groups. 
GCF scores were significantly lower for the AD group than for 
the MCI group (P<0.001), and GCF scores were significantly low-
er for the MCI group than for the NC group (P<0.001). In con-
trast, a post hoc analysis of MMSE scores revealed that there were 
no statistically significant differences between the NC and MCI 
groups (P=0.105), and that the only significant difference in MMSE 
scores was between the MCI and AD groups (P<0.001). 
  With respect to each of the cognitive domain scores, the three 
groups differed in each of the domains assessed: attention, lan-
guage and related function, visuospatial function, memory, and 
frontal/executive function (all P<0.001). Tukey’s post hoc anal-
yses of the domain scores revealed that there were significant 
differences between the NC and MCI groups, as well as between 
the MCI and AD groups in language and related function, mem-
ory, and frontal/executive function. However, in attention and 
visuospatial function, differences were only noted between the 
MCI and AD groups, but not between the NC and MCI groups. 
  The same analyses were performed to examine each of the 
sub-test scores individually. Overall group differences were pres-
ent in all tests at the significance level of P<0.001, with the excep-
tion of the motor impersistence test (P=0.072) from the frontal/
executive function sub-domain. Post hoc analyses revealed that 
there were significant differences between the NC and MCI 
groups, as well as between the MCI and AD groups on the K-
BNT; the immediate recall, delayed recall, and the recognition 
of the SVLT; the immediate and delayed recall, as well as the 
recognition of the RCFT; and the category word generation test. 
However, in the remaining sub-tests, including forward digit 
span, backward digit span, the calculation task, the RCFT copy 
and orientation task, contrasting program, go-no-go test, fist-
edge-palm test, the Luria loop task, and the word fluency test, 
there were statistically significant differences between the MCI 
and AD groups, but not between the NC and MCI groups.
Discriminant validity by CDR stage analysis
Participants were also classified according to the CDR score. As 
the CDR stage increased, the GCF score decreased: CDR 0 (211.0 
±24.3), 0.5 (146.1±36.7), 1 (93.6±27.1), 2 (55.2±26.6), and GCF 
scores differed significantly between the four CDR groups. There 
were also significant differences between each of the consecu-
tive pairs of CDR groups: CDR 0 vs. 0.5, CDR 0.5 vs. 1, and CDR 
1 vs. 2 (P<0.001). 
  To further examine the utility of the SNSB-D to discriminate 
according to dementia severity rating, participants were reclas-
sified into five groups according to CDR scores. Specifically, the 
NC group was assigned a CDR score of 0 (NC-0), MCI patients 
were assigned a CDR score of 0.5 (MCI-0.5), and AD patients 
were assigned a CDR score of 0.5 (AD-0.5), 1 (AD-1), or 2 (AD-
2), depending on the patient’s severity of dementia. According 
to post hoc analyses, the five CDR groups differed significantly 
with respect to GCF scores. Specifically, the GCF score decreas–
ed significantly as the CDR increased (Table 2). We were partic-
ularly interested in comparing the MCI-0.5 and AD-0.5 groups. 
Post hoc analyses revealed that the two groups differed signifi-
cantly across all cognitive domains except attention.
Convergent validity
In examining convergent validity, it was determined that SNSB-D 
GCF scores and MMSE scores were highly correlated (r=0.876). 
Additionally, each of the cognitive sub-domain scores of the 
SNSB-D was significantly correlated with the overall GCF score, 
as well as with the MMSE score. Specifically, it was found that 
the memory domain score had the highest correlation with the 
Fig. 1. Receiver operator characteristics (ROC) curves for the MMSE and the SNSB-D, divided by group.
S
e
n
s
i
t
i
v
i
t
y
S
e
n
s
i
t
i
v
i
t
y
1.0
0.8
0.6
0.4
0.2
0.0
1.0
0.8
0.6
0.4
0.2
0.0
1-Specificity 1-Specificity
NC & MCI MCI & AD
MMSE MMSE
SNSB-D SNSB-D
 0.0  0.2  0.4  0.6  0.8  1.0  0.0  0.2  0.4  0.6  0.8  1.0
A BAhn HJ, et al.  •  Seoul Neuropsychological Screening Battery-Dementia Version (SNSB-D)
DOI: 10.3346/jkms.2010.25.7.1071 http://jkms.org   1075
GCF among the five cognitive sub-domains, with the other cor-
relations as follows: attention (0.629), language and related func-
tion (0.848), visuospatial function (0.779), memory (0.945), fron-
tal/executive function (0.919). 
Reliability
Cronbach’s alphas for the SNSB-D were 0.797 in the AD group, 
0.710 in the MCI group, 0.637 in the NC group, and 0.871 for the 
full sample, suggesting a high level internal consistency. The test-
retest reliability of the GCF score was assessed using Pearson 
correlation coefficients. Test-retest reliability was high, with a 
correlation coefficient of 0.978 for the whole sample, 0.918 for 
the AD group, 0.999 for the MCI group, and 0.960 for the NC group.
Diagnostic utility
We used the ROC curve analysis and calculated the area under 
the curve (AUC), as a measure of diagnostic utility for the SNSB-
D. First, in discriminating the MCI group from the NC group, the 
AUC of the SNSB-D was 0.883 and the SNSB-D had a sensitivity 
of 0.844 and a specificity of 0.814, with a cut-off score of 188.25 
(Table 3, Fig. 1A). The AUC of the SNSB-D GCF score was signif-
icantly superior to the MMSE (AUC=0.716, P=0.001). Second, in 
discriminating the MCI group from the AD group, the AUC of the 
SNSB-D was 0.939 and the appropriate SNSB-D cut-off score 
was 134.25 with a sensitivity of 0.860 and a specificity of 0.860 
Table 3. AUCs and cut-off scores for the SNSB-D GCF score and the MMSE global 
score
Global score NC and MCI MCI and AD
SNSB-D global score
   AUC
   Cut-off
   Sensitivity
   Specificity
0.883
188.25
0.844
0.814
0.939
134.25
0.860
0.860
MMSE global score
   AUC
   Cut-off
   Sensitivity
   Specificity
0.716
28.5
0.610
0.698
0.942
25.5
0.837
0.882
AUC, area under the curve; MMSE, Mini-Mental State Examination; SNSB-D, dementia 
version of Seoul Neuropsychological Screening Battery; GCF, global cognitive function.
(Table 3, Fig. 1B). The AUC of the MMSE (0.942) was compara-
ble to that of the SNSB-D (P=0.842). 
DISCUSSION
The SNSB-D is a neuropsychological test battery designed to as-
sess attention, language and related function, visuospatial func-
tion, memory, and frontal/executive function. Summing across 
the cognitive sub-domains results in a global cognitive function-
ing score. For constructing a GCF score from the cognitive sub-
domain scores, the ideal proportion of each domain score is not 
known. Therefore, we thought it was worthwhile to compare the 
construct and proportion of cognitive domain scores of SNSB-D 
with those of other tests that have global and subscale scores and 
the results are as follows. As shown in Table 4, the SNSB-D was 
compared with the MMSE (9), Mattis Dementia Rating Scale 
(DRS) (10), Alzheimer’s Disease Assessment Scale-Cognitive 
Subscale (ADAS-cog) (11), and Consortium to Establish a Reg-
istry for Alzheimer’s Disease (CERAD) (12). All prior tests, with 
the exception of the DRS, share the feature of having a memory 
domain which represents approximately 50% of the total score. 
The proportions of the other cognitive domains comprising the 
global score were variable among tests. The MMSE does not have 
tests for frontal/executive function (9). The DRS contains no tests 
for language function, and compared to memory function it as-
signs a higher proportion to executive function (10). The ADAS-
cog does not include items that measure attention or frontal/
executive function (11). Recently a global scoring system for the 
CERAD was proposed by Chandler et al. (12), however, this mea-
sure does not have an attention sub-domain. In comparison to 
these tests, the SNSB-D contains tests that assess attention (6%), 
memory (50%), language (9%), visuospatial function (12%), and 
frontal-executive function (23%). Given that memory decline is 
the earliest change observed in most patients with dementia and 
MCI, the proportion of 50% in the memory domain is likely to 
be appropriate. 
  The SNSB-D was shown to have good internal consistency 
and high test-retest reliability. Additionally, we wanted to see if 
the SNSB-D GCF score could discriminate among the NC, MCI 
Table 4. Cognitive sub-domain composition of the neuropsychological tests
Cognitive function
MMSE DRS ADAS-cog CERAD SNSB-D
Points (%) Points (%) Points (%) Points (%) Points (%)
Attention   5 (17)   37 (26) - - - -   17 (6)
Language   8 (27) - - 25 (36)   15 (15)   17 (9)
Visuospatial function   1 (3)     6 (4)   5 (7)   11 (11)   36 (12)
Praxis - - - -   5 (7) - - - -
Memory & orientation 16 (53)   25 (17) 35 (50)   50 (50) 150 (50)
Frontal/Executive function - -   76 (53) - -   24 (24)   70 (23)
Global scores (%) 30 (100) 144 (100) 70 (100) 100 (100) 300 (100)
MMSE, Mini-Mental State Examination; DRS, Dementia Rating Scale; ADAS-cog, Alzheimer’s Disease Assessment Scale-Cognitive Subscale; CERAD, Consortium to Establish a 
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and AD groups. We found that the GCF was able to distinguish 
each group effectively. In contrast, the MMSE score was unable 
to discriminate between the MCI (27.2±1.9) and NC (28.6±1.4) 
groups; although it was able to discriminate between the MCI 
and AD groups. GCF scores could also discriminate between each 
of the CDR stages. GCF scores declined significantly as CDR scores 
increased, confirming that the SNSB-D is able to discriminate 
the stages of the CDR. Both MCI and early stages of AD can be 
assigned a CDR score of 0.5. Thus, we were particularly interest-
ed in whether the GCF score might differentiate between MCI 
patients and AD patients with CDR scores of 0.5. The results show–
ed that these two groups differed significantly in terms of the 
GCF scores. Therefore, the SNSB-D may serve as a useful tool 
that can discriminate not only MCI, AD, and normal aging, but 
also distinguish AD patients at different stages on the CDR scale. 
  We considered the diagnostic utility of the GCF scores derived 
from the SNSB-D by comparing the SNSB-D with the MMSE, 
using a ROC curve analysis. Generally, an AUC above 0.85 is re-
garded as a strong diagnostic value (13). In discriminating be-
tween the NC and MCI groups, the AUC of the SNSB-D was 0.883, 
whereas the AUC of the MMSE was 0.716, suggesting that the 
utility of SNSB-D is superior to that of MMSE for differentiating 
MCI from controls. Likewise, the SNSB-D had AUC values above 
0.85 when discriminating among patients with MCI and AD at 
differing severity levels, indicating that the SNSB-D is more sen-
sitive than the MMSE in discriminating between MCI and the 
early stages of AD.
  Although the SNSB has been widely used to diagnose demen-
tia for clinical, as well as, research purposes in Korea, the absence 
of a global score has resulted in a lack of longitudinal, follow-up 
investigations of cognitive function in patients with dementia. 
In this study, we have demonstrated that the SNSB-D, with its 
global and domain-specific scores, is a valid and reliable instru-
ment for assessing individuals ranging from normal levels of 
cognitive function to MCI or AD. This new instrument will also 
be helpful to monitor the progression of global and domain-spe-
cific cognition over time. Furthermore, although the utility of 
SNSB-D has not been verified in other dementing disorders, 
since the SNSB-D consists of tests that cover various cognitive 
domains, the GCF score and sub-domain scores of SNSB-D could 
be used to assess and monitor cognitive dysfunctions in patients 
with other types of dementia.
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